RecruitingNCT05889013

Utility of PCD Diagnostics to Improve Clinical Care

A Clinical Study to Gather Data on the Utility of Tests That Are Used to Make a Diagnosis of Primary Ciliary Dyskinesia (PCD)


Sponsor

Connecticut Children's Medical Center

Enrollment

50 participants

Start Date

Oct 17, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

This cross-sectional and longitudinal observational study is to gather data on the utility of tests that are used to make a diagnosis of primary ciliary dyskinesia (PCD). There is new testing available, called nasal nitric oxide testing, that non-invasively measures nitric oxide levels in the sinus cavity. Individuals with PCD characteristically have low levels, but this testing does not have extensive data from everyday clinical practice. The objective of this proposal is to improve the diagnostic approach to children and adults with clinical concerns for primary ciliary dyskinesia (PCD).


Eligibility

Min Age: 2 Years

Inclusion Criteria8

  • Age ≥ 2 years of age
  • Must have two of the following clinical history points:
  • Neonatal respiratory distress
  • Chronic nasal congestion/runny nose
  • Chronic cough
  • Situs/laterality defects
  • Bronchiectasis
  • Ability to provide informed consent or consent of parent/guardian and ass

Exclusion Criteria7

  • Recent history of sinus surgery or bloody nose in the past week
  • Age \< 2 years of age
  • Inability to tolerate probe in nose
  • Sinusitis or other respiratory exacerbation currently being treated with antibiotics
  • Admitted to hospital for respiratory exacerbation (inpatient status)
  • Inability to understand the requirements of the study or be unwilling to provide written informed consent (as evidenced by signature on an informed consent document approved by the IRB)
  • Any other reason for which the study investigators feel the patient is not a good candidate to complete the testing

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICENasal Nitric Oxide testing

Collection of already performed clinical data and nNO testing


Locations(1)

Pulmonary Division

Hartford, Connecticut, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05889013


Related Trials